# FDA Press Releases RSS Feed

- FDA Roundup: January 30, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 26, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 23, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 19, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 16, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 12, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: January 9, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Facilitates Broader Adoption of Vaporized Hydrogen Peroxide for Medical Device Sterilization Today, the FDA is announcing that it considers vaporized hydrogen peroxide (VHP) to be an established method of sterilization for medical devices, recognizing VHP’s long history of safety and effectiveness.
- FDA Roundup: January 5, 2024 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Authorizes Florida’s Drug Importation Program FDA authorized Florida’s Agency for Health Care Administration’s Section 804 Importation Program (SIP) in accordance with section 804 of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) and the FDA’s implementing regulations.
- FDA Roundup: January 2, 2024 FDA Roundup: January 2, 2024
- FDA Roundup: December 22, 2023 FDA Roundup: December 22, 2023
- FDA Roundup: December 19, 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- FDA Roundup: December 15, 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
- Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs The U.S. District Court for the District of Massachusetts entered a consent decree of permanent injunction ordering Pharmasol Corporation, a Massachusetts-based company.
- Joint Federal Operation Results in Seizure of More Than $18 Million in Illegal E-Cigarettes Today, the U.S. Food and Drug Administration, in collaboration with U.S. Customs and Border Protection (CBP), announced the seizure of approximately 1.4 million units of unauthorized e-cigarette products.
- FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals The FDA is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law.
- FDA Advances Reorganization Proposal for Unified Human Foods Program, Field Operations and Additional Modernization Efforts The FDA is providing an update on its efforts to create a unified Human Foods Program and new ORA model, including additional details about the proposed structure, status of activities and timeline for next steps.
- FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments The FDA is creating a new advisory committee related to potential treatments for genetic metabolic diseases. Genetic metabolic diseases are conditions that disrupt an individual&#039;s metabolism, which is the chemical process responsible for converting food into energy and eliminating toxins from the bo
- FDA Roundup: December 8, 2023 The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.